The vascular access catheters market, valued at approximately USD 3.0 billion by the end of 2022, is expected to experience ...

The "Peripheral Embolic Protection Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" report has been added to ...

RenovoRx, Inc. ("RenovoRx” or the "Company”) (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and offering RenovoCath, a novel, FDA-cleared local drug-delivery ...

November 13, 2024—R3 Vascular Inc. recently announced that the FDA granted investigational device exemption (IDE ... eluting bioresorbable scaffold for treating below-the-knee (BTK) peripheral ...

Solaris Endovascular today announced its formation to develop solutions for dialysis access and treating peripheral artery ...

Over 50% of these patients experience vascular access failures ... a growth stage US-based medical device company developing advanced endovascular solutions for patients suffering from dialysis access ...

Philips has now developed a device intended to integrate two forms of laser-based PAD therapy, atherectomy and intravascular ...

Cardiovascular disease, sometimes abbreviated as CVD, is the leading cause of death worldwide. It’s a catchall term for heart ...

The "Plaque Modification Devices - Market Insights, Competitive Landscape, Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.The plaque modification devices market was valued ...

Avinger Inc. ( (AVGR) ) has released its Q3 earnings. Here is a breakdown of the information Avinger Inc. presented to its investors. Avinger, ...

Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET. Company Participants. Matthew Kreps - Investor Relations Jeffrey Soinski - Chief Executiv ...